Effects of 2-amino-4,6-dinitrotoluene on p53 tumor suppressor gene expression

Hirendra Banerjee1, Zack Hawkins, Sisir Dutta

  • 1Department of Biology, Elizabeth City State University, NC 27909, USA. bhirendranath@mail.ecsu.edu

Insights

2-Amino-4,6-dinitrotoluene (2-Am-DNT), a common TNT metabolite, may cause cancer. Studies show it increases p53 protein levels in breast cancer cells, indicating potential carcinogenic effects.

Area of Science:

  • Environmental Toxicology
  • Molecular Biology
  • Cancer Research

Background:

  • 2-Amino-4,6-dinitrotoluene (2-Am-DNT) is a primary metabolite of 2,4,6-trinitrotoluene (TNT).
  • Concerns exist regarding 2-Am-DNT's toxicity, carcinogenicity, and potential drinking water contamination.
  • The p53 tumor suppressor gene plays a critical role in cellular response to DNA damage and cancer development.

Purpose of the Study:

  • To investigate the potential carcinogenic effects of 2-Am-DNT.
  • To determine if 2-Am-DNT exposure influences p53 protein levels and activity in human breast cancer cells.

Main Methods:

  • MCF-7 human breast cancer cells, with wild-type p53, were treated with 2-Am-DNT.
  • Immunoblotting was used to detect p53 protein levels.
  • p53 DNA-protein binding assays (gel-shift) were performed to assess p53 activity.

Main Results:

  • Treatment with 2-Am-DNT led to enhanced p53 protein levels in MCF-7 cells compared to controls.
  • p53 DNA-protein binding assays confirmed the accumulation of p53 protein in treated cells.
  • This is the first study to demonstrate p53 accumulation in response to 2-Am-DNT exposure.

Conclusions:

  • 2-Am-DNT exposure induces p53 accumulation in human breast cancer cells.
  • The observed p53 response provides evidence for the potential carcinogenicity of 2-Am-DNT.
  • Further research is warranted to fully elucidate the toxicological profile of 2-Am-DNT.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...